The forecast for prostate malignant neoplasms mortality in Belgium from 2024 to 2028 shows a relatively stable trend with a slight increase. The mortality rate is expected to be 28.3 units (male deaths per hundred thousand men) in 2024 and 2025, rising marginally to 28.4 from 2026 to 2028. For context, the rate in 2023 stood at 28.3. Year-on-year, the variation is minimal at around 0.35% from 2025 to 2026 and no variation from 2024 to 2025. The Compound Annual Growth Rate (CAGR) over the last five years is expected to be approximately 0.13%.
Future trends to watch for include advancements in medical treatments, early detection methods, and potential lifestyle changes that could impact mortality rates. Additionally, monitoring the impact of healthcare policy changes could provide further insights into the long-term trends in mortality rates due to prostate malignant neoplasms.
